Market Opportunity - We Help You Fill the Need

Overview - The Problem and The Numbers

The Market — Obstructive Sleep Apnea (OSA) is a serious and potentially life-threatening sleep disorder that afflicts as many as 18 million Americans of which only 5% have been diagnosed. The U.S. represents approximately half of the worldwide market opportunity for OSA testing. Once properly diagnosed, highly effectively treatments are available.

The National Sleep Foundation (NSF) statistics reveal that approximately 40 million people suffer from chronic sleep disorders. It is estimated that 85 to 90% of these individuals remain undiagnosed, representing a large untapped market. In 2008, the Obstructive Sleep Apnea therapy device and sleep diagnostic system markets were the fastest growing segments in healthcare. This was due to the rising prevalence of sleep disorders, as well as the increased awareness of the diagnosis and treatment of these conditions.

Five Million Americans are presently diagnosed with  CHF. There are 400,000 new cases diagnosed each  year (1,100/day). 68% of patients with CHF also have  Obstructive Sleep Apnea. CHF Patients that have Obstructive Sleep Apnea have a 56% 3yr mortality rate  vs. 11% on patients without Obstructive Sleep Apnea.

Forty five Million Americans have Hypertension, it is the fastest growing health problem in the U.S. 40% of patients with hypertension also have Obstructive Sleep Apnea (Sin et al, 2001).

Twenty one Million Americans suffer from Diabetes. 50% of patients with Type II Diabetes have Obstructive Sleep Apnea. There has been a 76% increase in Type II diabetes in adults 30-40 yrs old since 1990.

It is well known that anesthetic, opiate, and sedative agents are central nervous system (CNS) depressants that increase the tendency for upper airway collapse. This makes any patient that has to undergo surgery or is on any type of strong pain medications a potential candidate for sleep apnea testing. These CNS effects may be significantly worse in OSA patients as the decreased arousal response to breathe leads to prolonged apnea and the potential for respiratory and cardiovascular arrest.

Click here to read more.